MKLOX
Price
$19.74
Change
-$0.11 (-0.55%)
Updated
Nov 13 closing price
RLBEX
Price
$36.56
Change
-$0.05 (-0.14%)
Updated
Nov 13 closing price
Ad is loading...

MKLOX vs RLBEX

Header iconMKLOX vs RLBEX Comparison
Open Charts MKLOX vs RLBEXBanner chart's image
BlackRock Global Allocation K
Price$19.74
Change-$0.11 (-0.55%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R4
Price$36.56
Change-$0.05 (-0.14%)
VolumeN/A
CapitalizationN/A
MKLOX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MKLOX vs. RLBEX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKLOX is a Buy and RLBEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 240B vs. MKLOX (17B). RLBEX pays higher dividends than MKLOX: RLBEX (2.24) vs MKLOX (1.61). MKLOX was incepted earlier than RLBEX: MKLOX (8 years) vs RLBEX (22 years). MKLOX (174.00) and RLBEX (171.00) have comparable annual turnover. RLBEX has a lower initial minimum investment than MKLOX: RLBEX (250) vs MKLOX (5000000). RLBEX annual gain was more profitable for investors over the last year : 24.74 vs. MKLOX (15.85). RLBEX return over 5 years is better than : 38.53 vs. MKLOX (6.06).
MKLOXRLBEXMKLOX / RLBEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years22 years-
Gain YTD7.10815.73545%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets17B240B7%
Annual Yield % from dividends1.612.2472%
Returns for 1 year15.8524.7464%
Returns for 3 years-9.0412.07-75%
Returns for 5 years6.0638.5316%
Returns for 10 yearsN/A55.31-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCS13.22-0.26
-1.93%
Barclays PLC
IPAR126.00-2.80
-2.17%
Interparfums Inc
KALA7.14-0.27
-3.58%
Kala BIO
KW11.10-0.60
-5.13%
Kennedy-Wilson Holdings
ALDX4.76-0.73
-13.30%
Aldeyra Therapeutics